Medtronic (MDT) Expands Partnership with Merit Medical for ViaVerte System

Medtronic plc (NYSE:MDT) is included among the Dividend Kings and Aristocrats List: 32 Biggest Stocks.

Medtronic (MDT) Expands Partnership with Merit Medical for ViaVerte System

On March 24, Medtronic plc (NYSE:MDT) said it has entered into a distribution agreement with Merit Medical Systems to offer the FDA-cleared ViaVerte™ system. The product is a minimally invasive, implant-free basivertebral nerve ablation (BVNA) system. It is designed with a physician-controlled steerable mechanism to allow more precise targeting of the basivertebral nerve for treating chronic vertebrogenic lower back pain.

The agreement builds on Medtronic’s recent push to expand its core franchises through strategic partnerships. It also extends its existing relationship with Merit Medical. Merit already supplies components used in Medtronic’s Kyphon™ procedures, including Xpander™ Inflation Syringes and the KyphoFlex™ unipedicular steerable balloon catheter for vertebral compression fractures.

Data from the American Chronic Pain Association shows that about one in three Americans lives with some form of chronic pain.

BVNA has emerged as a growing treatment option for patients dealing with chronic low back pain linked to damaged vertebral endplates. The ViaVerte™ system is expected to be available later this year and is designed to support a same-day outpatient procedure.

Medtronic said the addition strengthens its broader pain management portfolio and supports its goal of expanding treatment options for patients and healthcare providers. Its existing portfolio includes spinal cord stimulation, vertebral augmentation, nerve ablation, bone tumor ablation, and targeted drug delivery. The inclusion of a steerable BVNA system adds another option to address rising demand in this area.

Medtronic plc (NYSE:MDT) develops and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients across the United States, Ireland, and other international markets.

While we acknowledge the risk and potential of MDT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MDT and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Dividend Stocks to Buy for Steady Income and 14 Under-the-Radar High Dividend Stocks to Buy Now

Disclosure: None. Follow Insider Monkey on Google News.